Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Foretinib> ?p ?o }
Showing triples 1 to 69 of
69
with 100 triples per page.
- Foretinib abstract "Foretinib is an experimental drug candidate for the treatment of cancer. It was discovered by Exelixis and is under development by GlaxoSmithKline. It is currently in Phase II clinical trials. As of December 2012 no phase III trials are registered.Foretinib is an inhibitor of the kinase enzymes c-Met and vascular endothelial growth factor receptor 2 (VEGFR-2).".
- Foretinib iupacName "N1’-[3-fluoro-4-[[6-methoxy-7-(3-morpholinopropoxy)-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide".
- Foretinib thumbnail Foretinib.svg?width=300.
- Foretinib wikiPageID "32646703".
- Foretinib wikiPageLength "3274".
- Foretinib wikiPageOutDegree "15".
- Foretinib wikiPageRevisionID "670403038".
- Foretinib wikiPageWikiLink C-Met.
- Foretinib wikiPageWikiLink C-Met_inhibitors.
- Foretinib wikiPageWikiLink Cabozantinib.
- Foretinib wikiPageWikiLink Category:Cyclopropanes.
- Foretinib wikiPageWikiLink Category:Experimental_cancer_drugs.
- Foretinib wikiPageWikiLink Category:Morpholines.
- Foretinib wikiPageWikiLink Category:Organofluorides.
- Foretinib wikiPageWikiLink Category:Quinolines.
- Foretinib wikiPageWikiLink Category:Tyrosine_kinase_inhibitors.
- Foretinib wikiPageWikiLink Exelixis.
- Foretinib wikiPageWikiLink GlaxoSmithKline.
- Foretinib wikiPageWikiLink Kinase_insert_domain_receptor.
- Foretinib wikiPageWikiLink Tyrosine-kinase_inhibitor.
- Foretinib wikiPageWikiLink VEGFR_inhibitor.
- Foretinib wikiPageWikiLink VEGF_receptors.
- Foretinib wikiPageWikiLink Vascular_endothelial_growth_factor_receptor_2.
- Foretinib wikiPageWikiLinkText "Foretinib".
- Foretinib wikiPageWikiLinkText "GSK 1363089".
- Foretinib wikiPageWikiLinkText "XL880".
- Foretinib wikiPageWikiLinkText "foretinib".
- Foretinib hasPhotoCollection Foretinib.
- Foretinib imagefile "Foretinib.svg".
- Foretinib imagesize "250".
- Foretinib iupacname "N1’-[3-fluoro-4-[[6-methoxy-7--4-quinolyl]oxy]phenyl]-N1-cyclopropane-1,1-dicarboxamide".
- Foretinib othernames "XL880; EXEL-2880; GSK1363089; GSK089".
- Foretinib wikiPageUsesTemplate Template:As_of.
- Foretinib wikiPageUsesTemplate Template:Chembox.
- Foretinib wikiPageUsesTemplate Template:Reflist.
- Foretinib subject Category:Cyclopropanes.
- Foretinib subject Category:Experimental_cancer_drugs.
- Foretinib subject Category:Morpholines.
- Foretinib subject Category:Organofluorides.
- Foretinib subject Category:Quinolines.
- Foretinib subject Category:Tyrosine_kinase_inhibitors.
- Foretinib hypernym Candidate.
- Foretinib type Article.
- Foretinib type ChemicalCompound.
- Foretinib type ChemicalSubstance.
- Foretinib type Drug.
- Foretinib type Person.
- Foretinib type Article.
- Foretinib type Drug.
- Foretinib type Ether.
- Foretinib type Heterocycle.
- Foretinib type Inhibitor.
- Foretinib type Organofluoride.
- Foretinib type Organohalide.
- Foretinib type Organofluoride.
- Foretinib type Organohalide.
- Foretinib type ChemicalObject.
- Foretinib type Thing.
- Foretinib type Q11173.
- Foretinib comment "Foretinib is an experimental drug candidate for the treatment of cancer. It was discovered by Exelixis and is under development by GlaxoSmithKline. It is currently in Phase II clinical trials. As of December 2012 no phase III trials are registered.Foretinib is an inhibitor of the kinase enzymes c-Met and vascular endothelial growth factor receptor 2 (VEGFR-2).".
- Foretinib label "Foretinib".
- Foretinib sameAs m.0h3thyt.
- Foretinib sameAs Foretinib.
- Foretinib sameAs Foretinib.
- Foretinib sameAs Q5469311.
- Foretinib sameAs Q5469311.
- Foretinib wasDerivedFrom Foretinib?oldid=670403038.
- Foretinib depiction Foretinib.svg.
- Foretinib isPrimaryTopicOf Foretinib.